Christian Hackenberger studied chemistry at the Universität Freiburg and the University of Wisconsin-Madison and performed his doctoral studies at the RTWH Aachen. After a postdoctoral stay at MIT, he started his group at the Freie Universität Berlin in 2005 as an Emmy Noether fellow. In 2012, he became Leibniz-Humboldt Professor for Chemical Biology at the Leibniz-Research Institute for Molecular Pharmacology and the Humboldt Universität zu Berlin. His group develops chemical strategies to functionalize proteins and antibodies, in particular using chemoselective Staudinger reactions and electrophilic P(V)-reagents, to generate protein and antibody-based biopharmaceuticals against cancer, neurodegenerative diseases and viral infections. He is a co-founder of the company Tubulis, which engineers better tolerable cancer drugs using among others technologies from his lab.